Medicinova (MNOV) Non-Current Deferred Tax Liability (2010 - 2025)
Medicinova's (MNOV) quarterly Non-Current Deferred Tax Liability came in at $201792.0 in Q4 2025, little changed year-on-year from $201792.0 in Q4 2024, and little changed on a QoQ basis from $201792.0 in Q3 2025.
Medicinova (MNOV) Non-Current Deferred Tax Liability (2010 - 2025) Analysis & Trends
Medicinova (MNOV) has 16 years of Non-Current Deferred Tax Liability data on file, last reported at $201792.0 in Q4 2025.
- On a quarterly basis, Non-Current Deferred Tax Liability changed 0.0% year-over-year to $201792.0 in Q4 2025; TTM through Dec 2025 was $201792.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $201792.0, changed 0.0% from the prior year.
- Non-Current Deferred Tax Liability for Q4 2025 stood at $201792.0, roughly flat from $201792.0 in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for MNOV reached as high as $201792.0 in Q1 2021 and fell as low as $201792.0 in Q1 2021.
- Historically, Non-Current Deferred Tax Liability has averaged $201792.0 across 5 years, with a median of $201792.0 in 2021.
- On a YoY basis, Non-Current Deferred Tax Liability climbed as much as 0.0% in 2021 and fell as far as 0.0% in 2021.
- Year by year, Non-Current Deferred Tax Liability stood at $201792.0 in 2021, then changed by 0.0% to $201792.0 in 2022, then changed by 0.0% to $201792.0 in 2023, then changed by 0.0% to $201792.0 in 2024, then changed by 0.0% to $201792.0 in 2025.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $201792.0 in Q4 2025, $201792.0 in Q3 2025, and $201792.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Medicinova | 64.48 Mn | 64.48 Mn | 4,754.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 201,792.00 |
| Dec 31, 2025 | 201,792.00 |
| Sep 30, 2025 | 201,792.00 |
| Sep 30, 2025 | 201,792.00 |
| Jun 30, 2025 | 201,792.00 |
| Jun 30, 2025 | 201,792.00 |
| Mar 31, 2025 | 201,792.00 |
| Mar 31, 2025 | 201,792.00 |
| Dec 31, 2024 | 201,792.00 |
| Dec 31, 2024 | 201,792.00 |
| Sep 30, 2024 | 201,792.00 |
| Sep 30, 2024 | 201,792.00 |
| Jun 30, 2024 | 201,792.00 |
| Jun 30, 2024 | 201,792.00 |
| Mar 31, 2024 | 201,792.00 |
| Mar 31, 2024 | 201,792.00 |
| Dec 31, 2023 | 201,792.00 |
| Dec 31, 2023 | 201,792.00 |
| Sep 30, 2023 | 201,792.00 |
| Sep 30, 2023 | 201,792.00 |